Skip to main content
Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · S2P ISIN · HK0000658531 HKEX Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2023-09-29 Transaction in Own Shar…
Country CN China
Listing HKEX S2P

About Simcere Pharmaceutical Group Limited

https://www.simcere.com/en/

Simcere Pharmaceutical Group Limited is an R&D-driven pharmaceutical company specializing in the discovery, development, and commercialization of innovative and branded generic prescription drugs. The company strategically focuses on core therapeutic areas, including neuroscience, anti-oncology, and inflammatory diseases. Simcere emphasizes synergistic innovation, evidenced by its development and launch of multiple Category I innovative pharmaceuticals and its strategic collaborations with global partners to advance novel treatments. These partnerships aim to address significant unmet medical needs and expand the company's portfolio across specialized disease areas.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details repurchases of shares on various dates, quantities, prices, and confirms compliance with listing rules. The content is focused on reporting share repurchase transactions and changes in issued shares, with no financial statements or earnings data. This matches the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is over 12,000 characters and contains detailed transactional data, not just an announcement or certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-09-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details multiple repurchases of shares over several dates, including quantities and prices, and confirms compliance with listing rules. The content is focused on reporting share repurchase transactions and capital changes, not on financial results, management changes, or other report types. This matches the definition of 'Transaction in Own Shares' filings, which report company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-09-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details repurchases of shares on various dates, quantities, prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive data about share repurchases. The content fits the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2023-09-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details repurchases of shares on various dates, confirming compliance with listing rules and providing specifics on the number of shares repurchased, prices, and confirmations by an executive director. The content focuses on share repurchase activities rather than financial results, management changes, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document length and detail confirm it is not a brief announcement but a formal disclosure of share repurchase transactions.
2023-09-25 English
2023 INTERIM REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT 2023' and contains detailed financial highlights, management discussion and analysis, corporate information, auditor's review report, and consolidated financial statements for the six months ended June 30, 2023. It includes substantive financial data and analysis, such as revenue figures, profit, earnings per share, and notes to the unaudited interim financial report. The presence of an auditor's review report and detailed financial statements confirms this is a comprehensive financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2023-09-22 English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF INTERIM REPORT 2023
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated September 25, 2023, informing non-registered shareholders about the publication of the company's Interim Report 2023. It provides instructions on how to access the report online and how to request printed versions of this and future corporate communications. The document does not contain the actual interim report or substantive financial data but serves as a notice of publication and a request form for receiving printed copies. According to the 'MENU VS MEAL' rule, such a document is classified as a Report Publication Announcement (RPA) rather than the Interim Report (IR) itself.
2023-09-22 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.